𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relation of hepatitis C virus genotypes to risk factors and hepatic disease in Spanish patients

✍ Scribed by P. Alonso Alonso; A. Orduña; A. San Miguel; E. Dominguez; M. A. Bratos; M. P. Gutierrez; J. M. Eiros; L. Inglada; J. M. Gonzalez Hernandez; A. Rodriguez Torres

Book ID
111107448
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
504 KB
Volume
3
Category
Article
ISSN
1198-743X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical characteristics and antibody pr
Clinical characteristics and antibody profiles of chronic hepatitis C patients: Relation to hepatitis C virus genotypes
✍ Nobukazu Yuki; Norio Hayashi; Eiji Mita; Hideki Hagiwara; Masahide Oshita; Kazuy 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 671 KB

## Abstract Genotyping of 179 consecutive Japanese chronic hepatitis C patients was carried out based on the variation in the hepatitis C virus (HCV) core gene. The results were correlated with clinical features and antibody responses toward specific HCV proteins deduced from the nucleotide sequenc

Hepatitis B virus subtypes and hepatitis
Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal
✍ Santosh Man Shrestha; Fumio Tsuda; Hiroaki Okamoto; Hajime Tokita; Minoru Horiki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

A total of 146 patients with chronic liver disease, including 20 with chronic hepatitis, 63 with cirrhosis and 62 with primary hepatocellular carcinoma from Nepal were tested for markers of hepatitis B virus or hepatitis C virus infection. HBsAg was detected in 57 (39%) and hepatitis C virus RNA in

Genotypes and titers of hepatitis C viru
Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
✍ Kunihiko Hino; Shigehiko Sainokami; Kazumi Shimoda; Shiro Iino; Yu Wang; Hiroaki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

## Abstract Interferon induces remission in about 50% of patients with chronic hepatitis C, but it is difficult to predict which patients will respond. Host and viral factors were evaluated for correlation with response to interferon in patients with chronic hepatitis C. Recombinant interferon alph